Published in Retrovirology on March 20, 2008
SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells. Nat Med (2012) 4.27
CD317/tetherin is enriched in the HIV-1 envelope and downregulated from the plasma membrane upon virus infection. J Virol (2010) 1.63
Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses. J Virol (2010) 1.17
β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release. Retrovirology (2011) 1.07
Maleic anhydride-modified chicken ovalbumin as an effective and inexpensive anti-HIV microbicide candidate for prevention of HIV sexual transmission. Retrovirology (2010) 1.02
EASY-HIT: HIV full-replication technology for broad discovery of multiple classes of HIV inhibitors. Antimicrob Agents Chemother (2010) 0.93
High natural permissivity of primary rabbit cells for HIV-1, with a virion infectivity defect in macrophages as the final replication barrier. J Virol (2010) 0.84
Inhibition of lentivirus replication by aqueous extracts of Prunella vulgaris. Virol J (2009) 0.83
Medicinal plants: a public resource for metabolomics and hypothesis development. Metabolites (2012) 0.82
Biological signature characteristics of primary isolates from human immunodeficiency virus type 1 group O in ex vivo human tonsil histocultures. J Virol (2009) 0.81
The antibacterial effect of sage extract (Salvia officinalis) mouthwash against Streptococcus mutans in dental plaque: a randomized clinical trial. Iran J Microbiol (2015) 0.79
Complement-Opsonized HIV-1 Overcomes Restriction in Dendritic Cells. PLoS Pathog (2015) 0.79
Inhibition of HIV-1 infection by aqueous extracts of Prunella vulgaris L. Virol J (2011) 0.78
3-hydroxyphthalic anhydride-modified human serum albumin as a microbicide candidate against HIV type 1 entry by targeting both viral envelope glycoprotein gp120 and cellular receptor CD4. AIDS Res Hum Retroviruses (2013) 0.78
A review study on the effect of Iranian herbal medicines against in vitro replication of herpes simplex virus. Avicenna J Phytomed (2016) 0.77
Anti-enterovirus 71 activities of Melissa officinalis extract and its biologically active constituent rosmarinic acid. Sci Rep (2017) 0.75
The Membrane-Proximal Region of C-C Chemokine Receptor Type 5 Participates in the Infection of HIV-1. Front Immunol (2017) 0.75
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods (1983) 114.35
Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat Med (1998) 8.62
Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc Natl Acad Sci U S A (1994) 8.48
HIV drug resistance. N Engl J Med (2004) 5.52
A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat Biotechnol (2002) 5.49
HIV-1 inhibition by a peptide. Nature (1993) 5.01
HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues. Immunity (2001) 3.43
Role of Vif in human immunodeficiency virus type 1 reverse transcription. J Virol (1996) 2.35
Microbicides and other topical strategies to prevent vaginal transmission of HIV. Nat Rev Immunol (2006) 2.28
Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide. Cell (2007) 2.22
Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy. Nat Rev Microbiol (2007) 2.07
Considerations and development of topical microbicides to inhibit the sexual transmission of HIV. Expert Opin Investig Drugs (2002) 2.06
The central globular domain of the nucleocapsid protein of human immunodeficiency virus type 1 is critical for virion structure and infectivity. J Virol (1995) 1.66
In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells. J Virol (2003) 1.63
Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity. AIDS (2002) 1.55
The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4. Curr Biol (2005) 1.48
Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1. J Virol (2001) 1.33
Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1. J Exp Med (2002) 1.23
Molecular umbrellas: a novel class of candidate topical microbicides to prevent human immunodeficiency virus and herpes simplex virus infections. J Virol (2007) 1.19
Expression of Nef downregulates CXCR4, the major coreceptor of human immunodeficiency virus, from the surfaces of target cells and thereby enhances resistance to superinfection. J Virol (2006) 1.17
Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor Nef. J Virol (2005) 1.13
Determinants of human immunodeficiency virus type 1 baseline susceptibility to the fusion inhibitors enfuvirtide and T-649 reside outside the peptide interaction site. J Virol (2004) 1.13
T20-insensitive HIV-1 from naive patients exhibits high viral fitness in a novel dual-color competition assay on primary cells. Virology (2005) 1.11
HIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcription. Proc Natl Acad Sci U S A (2007) 1.09
Antiviral effect of aqueous extracts from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitro. Planta Med (2006) 1.05
Primary T-cells from human CD4/CCR5-transgenic rats support all early steps of HIV-1 replication including integration, but display impaired viral gene expression. Retrovirology (2007) 0.94
Development of topical microbicides for prevention of human immunodeficiency virus and herpes simplex virus. Am J Reprod Immunol (2003) 0.89
Antiherpes effect of Melissa officinalis L. extracts. Acta Microbiol Bulg (1993) 0.81
ANTIVIRAL ACTIVITY OF MELISSA OFFICINALIS (LEMON BALM) EXTRACT. Proc Soc Exp Biol Med (1964) 0.80
Semen-derived amyloid fibrils drastically enhance HIV infection. Cell (2007) 5.23
HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor. Cell Host Microbe (2009) 4.36
SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells. Nat Med (2012) 4.27
HIV-1 buds predominantly at the plasma membrane of primary human macrophages. PLoS Pathog (2007) 2.44
Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides. PLoS Biol (2012) 2.03
Efficient nonviral gene delivery into primary lymphocytes from rats and mice. FASEB J (2006) 1.78
Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients. Hepatology (2013) 1.68
In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells. J Virol (2003) 1.63
Sensory neuropathy in human immunodeficiency virus/acquired immunodeficiency syndrome patients: protease inhibitor-mediated neurotoxicity. Ann Neurol (2006) 1.49
The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4. Curr Biol (2005) 1.48
HIV-1 Gag processing intermediates trans-dominantly interfere with HIV-1 infectivity. J Biol Chem (2009) 1.47
Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma. Cancer Res (2008) 1.43
Antagonism of CD317 restriction of human immunodeficiency virus type 1 (HIV-1) particle release and depletion of CD317 are separable activities of HIV-1 Vpu. J Virol (2010) 1.40
In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans. Proc Natl Acad Sci U S A (2011) 1.36
HIV-1 Vpu blocks recycling and biosynthetic transport of the intrinsic immunity factor CD317/tetherin to overcome the virion release restriction. MBio (2011) 1.30
The HIV-1 pathogenicity factor Nef interferes with maturation of stimulatory T-lymphocyte contacts by modulation of N-Wasp activity. J Biol Chem (2006) 1.25
Versatile biosynthetic engineering of sialic acid in living cells using synthetic sialic acid analogues. J Biol Chem (2001) 1.22
Synergistic properties of the terpenoids aromadendrene and 1,8-cineole from the essential oil of Eucalyptus globulus against antibiotic-susceptible and antibiotic-resistant pathogens. Phytomedicine (2010) 1.21
Screening for antiviral activities of isolated compounds from essential oils. Evid Based Complement Alternat Med (2011) 1.18
Expression of Nef downregulates CXCR4, the major coreceptor of human immunodeficiency virus, from the surfaces of target cells and thereby enhances resistance to superinfection. J Virol (2006) 1.17
Antiviral activity and mode of action of propolis extracts and selected compounds. Phytother Res (2010) 1.17
Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses. J Virol (2010) 1.17
Peptide nanofibrils boost retroviral gene transfer and provide a rapid means for concentrating viruses. Nat Nanotechnol (2013) 1.12
Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1. J Leukoc Biol (2005) 1.12
HIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcription. Proc Natl Acad Sci U S A (2007) 1.09
Comparative study on the antiviral activity of selected monoterpenes derived from essential oils. Phytother Res (2010) 1.08
Peripheral nerve-derived HIV-1 is predominantly CCR5-dependent and causes neuronal degeneration and neuroinflammation. Virology (2005) 1.07
β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release. Retrovirology (2011) 1.07
A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes. Gastroenterology (2012) 1.06
Conformation-specific display of 4E10 and 2F5 epitopes on self-assembling protein nanoparticles as a potential HIV vaccine. Chem Biol Drug Des (2012) 1.06
Antiviral effect of aqueous extracts from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitro. Planta Med (2006) 1.05
Restrictions to HIV-1 replication in resting CD4+ T lymphocytes. Cell Res (2013) 1.04
Adenovector-mediated hair cell regeneration is affected by promoter type. Acta Otolaryngol (2010) 1.03
HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas. J Clin Invest (2013) 1.01
Barotrauma and decompression illness of the inner ear: 46 cases during treatment and follow-up. Otol Neurotol (2007) 1.00
Architecture and regulation of the HIV-1 assembly and holding compartment in macrophages. J Virol (2011) 1.00
Tissue-resident macrophages are productively infected ex vivo by primary X4 isolates of human immunodeficiency virus type 1. J Virol (2005) 0.99
Melissa officinalis oil affects infectivity of enveloped herpesviruses. Phytomedicine (2008) 0.98
Antibacterial activity of essential oils from Eucalyptus and of selected components against multidrug-resistant bacterial pathogens. Pharm Biol (2011) 0.97
p21 regulates the HIV-1 restriction factor SAMHD1. Proc Natl Acad Sci U S A (2014) 0.97
The Nef protein of human immunodeficiency virus is a broad-spectrum modulator of chemokine receptor cell surface levels that acts independently of classical motifs for receptor endocytosis and Galphai signaling. Mol Biol Cell (2006) 0.96
Mechanism of herpes simplex virus type 2 suppression by propolis extracts. Phytomedicine (2009) 0.95
Mouse T-cells restrict replication of human immunodeficiency virus at the level of integration. Retrovirology (2008) 0.95
Factors predicting survival after diagnosis of laryngeal cancer. Oral Oncol (2011) 0.95
Primary T-cells from human CD4/CCR5-transgenic rats support all early steps of HIV-1 replication including integration, but display impaired viral gene expression. Retrovirology (2007) 0.94
Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial). Eur Arch Otorhinolaryngol (2008) 0.94
Construction and characterization of an HIV-1 group O infectious molecular clone and analysis of vpr- and nef-negative derivatives. Virology (2004) 0.93
Gene expression profiling identifies novel key players involved in the cytotoxic effect of Artesunate on pancreatic cancer cells. Biochem Pharmacol (2009) 0.92
An updated systematic review of the pharmacology of silymarin. Forsch Komplementmed (2007) 0.92
Reacquisition of Nef-mediated tetherin antagonism in a single in vivo passage of HIV-1 through its original chimpanzee host. Cell Host Microbe (2012) 0.92
Additional use of acupuncture to NSAID effectively reduces post-tonsillectomy pain. Eur Arch Otorhinolaryngol (2008) 0.92
Determinants in HIV-1 Nef for enhancement of virus replication and depletion of CD4+ T lymphocytes in human lymphoid tissue ex vivo. Retrovirology (2009) 0.91
Susceptibility of drug-resistant clinical herpes simplex virus type 1 strains to essential oils of ginger, thyme, hyssop, and sandalwood. Antimicrob Agents Chemother (2007) 0.90
Pharmacodynamics of adenovector distribution within the inner ear tissues of the mouse. Hear Res (2006) 0.90
Role of macrophages in HIV infection and persistence. Expert Rev Clin Immunol (2006) 0.90
Long-term effects of the "Heidelberg Model of Music Therapy" in patients with chronic tinnitus. Int J Clin Exp Med (2012) 0.89
HIV-1 Vpu's lipid raft association is dispensable for counteraction of the particle release restriction imposed by CD317/Tetherin. Virology (2012) 0.89
Pharmacovirological impact of an integrase inhibitor on human immunodeficiency virus type 1 cDNA species in vivo. J Virol (2009) 0.88
Development and validation of the Functional Rhinoplasty Outcome Inventory 17 (FROI-17). Rhinology (2014) 0.87
Antibacterial, antiviral, antiproliferative and apoptosis-inducing properties of Brackenridgea zanguebarica (Ochnaceae). J Pharm Pharmacol (2006) 0.87
Additive antimicrobial [corrected] effects of the active components of the essential oil of Thymus vulgaris--chemotype carvacrol. Planta Med (2009) 0.86
Impact of ethanolic lamiaceae extracts on herpesvirus infectivity in cell culture. Forsch Komplementmed (2008) 0.86
Measurable impact of acupuncture on mucosal swelling of inferior turbinates: a prospective, randomized, controlled study. Acta Otolaryngol (2015) 0.85
Acupuncture for nasal congestion: a prospective, randomized, double-blind, placebo-controlled clinical pilot study. Am J Rhinol Allergy (2009) 0.85
Efficacy of anise oil, dwarf-pine oil and chamomile oil against thymidine-kinase-positive and thymidine-kinase-negative herpesviruses. J Pharm Pharmacol (2008) 0.85
Melissa officinalis extract inhibits attachment of herpes simplex virus in vitro. Chemotherapy (2012) 0.85
Human cyclin T1 expression ameliorates a T-cell-specific transcriptional limitation for HIV in transgenic rats, but is not sufficient for a spreading infection of prototypic R5 HIV-1 strains ex vivo. Retrovirology (2009) 0.84
High natural permissivity of primary rabbit cells for HIV-1, with a virion infectivity defect in macrophages as the final replication barrier. J Virol (2010) 0.84
Surgical-handling properties of the titanium prosthesis in ossiculoplasty. Ear Nose Throat J (2005) 0.84
Impact of genotype and mutation type on health-related quality of life in patients with hereditary hemorrhagic telangiectasia. Acta Otolaryngol (2009) 0.83
Quantitation of endogenous nucleoside triphosphates and nucleosides in human cells by liquid chromatography tandem mass spectrometry. Anal Bioanal Chem (2015) 0.82
Phase III results with a totally implantable piezoelectric middle ear implant: speech audiometry, spatial hearing and psychosocial adjustment. Acta Otolaryngol (2004) 0.82
Biological activity of the essential oil of Kadsura longipedunculata (Schisandraceae) and its major components. J Pharm Pharmacol (2010) 0.81
Otorhinolaryngologic disorders and diving accidents: an analysis of 306 divers. Eur Arch Otorhinolaryngol (2007) 0.81
Biological signature characteristics of primary isolates from human immunodeficiency virus type 1 group O in ex vivo human tonsil histocultures. J Virol (2009) 0.81
Phosphorylation of AKT(Ser473) serves as an independent prognostic marker for radiosensitivity in advanced head and neck squamous cell carcinoma. Int J Cancer (2014) 0.80
Anti-herpetic properties of hydroalcoholic extracts and pressed juice from Echinacea pallida. Planta Med (2009) 0.80
Treating intermittent claudication with Tibetan medicine Padma 28: does it work? Atherosclerosis (2006) 0.80
High-level transfection of primary rabbit T lymphocytes. J Immunol Methods (2008) 0.80
In vitro antioxidant, antimicrobial and anti-herpes simplex virus type 1 activity of Phellodendron amurense Rupr. from China. Am J Chin Med (2009) 0.80
Reduced promoter methylation and increased expression of CSPG4 negatively influences survival of HNSCC patients. Int J Cancer (2014) 0.80
p16(INK4a) /Ki-67 co-expression specifically identifies transformed cells in the head and neck region. Int J Cancer (2014) 0.80
MxB/Mx2: the latest piece in HIV's interferon puzzle. EMBO Rep (2013) 0.79
Quality of life in patients with oropharyngeal carcinoma after primary surgery and postoperative irradiation. J Otolaryngol (2006) 0.79
Quality of life after septorhinoplasty measured with the Functional Rhinoplasty Outcome Inventory 17 (FROI-17). Rhinology (2015) 0.79
Age dependence of otoacoustic emissions: the loss of amplitude is primarily caused by age-related hearing loss and not by aging alone. Eur Arch Otorhinolaryngol (2009) 0.78
Safe and reliable sound threshold measures with direct vibration of the ossicular chain. Laryngoscope (2004) 0.78
Bactericidal properties of the antimicrobial peptide Ib-AMP4 from Impatiens balsamina produced as a recombinant fusion-protein in Escherichia coli. Biotechnol J (2013) 0.78
First experiences with a new adjustable length titanium ossicular prosthesis (ALTO). Acta Otolaryngol (2010) 0.78
Cytogenetic characterization of head and neck squamous cell carcinoma cell lines as model systems for the functional analyses of tumor-associated genes. J Oral Pathol Med (2010) 0.78
HIV pseudovirion vaccine exposing Env "fusion intermediates"-response to immunisation in human CD4/CCR5-transgenic rats. Vaccine (2009) 0.77